|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 2/26/21 AtriCure, Inc. 10-K 12/31/20 111:23M |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.91M
2: EX-10.17 Material Contract HTML 75K
3: EX-10.19 Material Contract HTML 40K
4: EX-10.20 Material Contract HTML 81K
5: EX-21 Subsidiaries List HTML 29K
6: EX-23.1 Consent of Expert or Counsel HTML 30K
7: EX-31.1 Certification -- §302 - SOA'02 HTML 39K
8: EX-31.2 Certification -- §302 - SOA'02 HTML 39K
9: EX-32.1 Certification -- §906 - SOA'02 HTML 36K
10: EX-32.2 Certification -- §906 - SOA'02 HTML 36K
17: R1 Document and Entity Information HTML 94K
18: R2 Consolidated Balance Sheets HTML 117K
19: R3 Consolidated Balance Sheets (Parenthetical) HTML 41K
20: R4 Consolidated Statements of Operations and HTML 100K
Comprehensive Loss
21: R5 Consolidated Statements of Stockholders' Equity HTML 84K
22: R6 Consolidated Statements of Cash Flows HTML 151K
23: R7 Consolidated Statements of Cash Flows HTML 31K
(Parenthetical)
24: R8 Description of Business and Summary of Significant HTML 152K
Accounting Policies
25: R9 Recent Accounting Pronouncements HTML 41K
26: R10 Fair Value HTML 385K
27: R11 Investments HTML 137K
28: R12 Business Combinations HTML 148K
29: R13 Intangible Assets and Goodwill HTML 125K
30: R14 Inventories HTML 58K
31: R15 Property and Equipment HTML 104K
32: R16 Accrued Liabilities HTML 77K
33: R17 Indebtedness HTML 59K
34: R18 Leases HTML 272K
35: R19 Commitments and Contingencies HTML 40K
36: R20 Revenue HTML 41K
37: R21 Income Taxes HTML 385K
38: R22 Concentrations HTML 36K
39: R23 Employee Benefit Plans HTML 36K
40: R24 Equity Compensation Plans HTML 753K
41: R25 Segment and Geographic Information HTML 183K
42: R26 Selected Quarterly Financial Data HTML 159K
43: R27 Schedule II - Valuation And Qualifying Accounts HTML 167K
44: R28 Description of Business and Summary of Significant HTML 204K
Accounting Policies (Policies)
45: R29 Description of Business and Summary of Significant HTML 116K
Accounting Policies (Tables)
46: R30 Fair Value (Tables) HTML 367K
47: R31 Investments (Tables) HTML 135K
48: R32 Business Combinations (Tables) HTML 136K
49: R33 Intangible Assets and Goodwill (Tables) HTML 124K
50: R34 Inventories (Tables) HTML 58K
51: R35 Property and Equipment (Tables) HTML 99K
52: R36 Accrued Liabilities (Tables) HTML 76K
53: R37 Indebtedness (Tables) HTML 47K
54: R38 Leases (Tables) HTML 270K
55: R39 Income Taxes (Tables) HTML 371K
56: R40 Equity Compensation Plans (Tables) HTML 733K
57: R41 Segment and Geographic Information (Tables) HTML 178K
58: R42 Selected Quarterly Financial Data (Tables) HTML 157K
59: R43 Description of Business and Summary of Significant HTML 43K
Accounting Policies (Narrative) (Details)
60: R44 Description of Business and Summary of Significant HTML 49K
Accounting Policies (Accumulated Other
Comprehensive Income (Loss)) (Details)
61: R45 Fair Value (Narrative) (Details) HTML 94K
62: R46 Fair Value (Financial Assets And Liabilities HTML 65K
Measured At Fair Value On A Recurring Basis)
(Details)
63: R47 Fair Value (Level 3 Fair Value Measurements Using HTML 53K
Significant Other Unobservable Inputs For
Acquisition-Related Contingent Consideration
(Recurring)) (Details)
64: R48 Fair Value (Level 3 Fair Value Measurements Using HTML 42K
Significant Other Unobservable Inputs For
Acquisition-Related Contingent Consideration)
(Details)
65: R49 Investments (Narrative) (Details) HTML 32K
66: R50 Investments (Summary Of Short-term Investments) HTML 48K
(Details)
67: R51 Business Combinations (Narrative) (Details) HTML 86K
68: R52 Business Combinations (Schedule of Components of HTML 40K
Aggregate Purchase Price) (Details)
69: R53 Business Combinations (Summary Of Estimated Fair HTML 64K
Values Of Assets Acquired And Liabilities Assumed)
(Details)
70: R54 Business Combinations (Valuation of Intangible HTML 40K
Assets Acquired and Related Amortization Periods)
(Details)
71: R55 Business Combination (Pro-forma Acquisition HTML 37K
Information) (Details)
72: R56 Intangible Assets and Goodwill (Narrative) HTML 43K
(Details)
73: R57 Intangible Assets and Goodwill (Company's HTML 45K
Intangible Assets) (Details)
74: R58 Intangible Assets and Goodwill (Future HTML 45K
Amortization Expense Related To Intangible Assets
With Definite Lives) (Details)
75: R59 Intangible Assets and Goodwill (Summary Of HTML 34K
Company's Goodwill) (Details)
76: R60 Inventories (Summary Of Inventories) (Details) HTML 39K
77: R61 Property and Equipment (Narrative) (Details) HTML 38K
78: R62 Property and Equipment (Summary Of Property And HTML 73K
Equipment) (Details)
79: R63 Accrued Liabilities (Accrued Liabilities) HTML 51K
(Details)
80: R64 Indebtedness (Narrative) (Details) HTML 67K
81: R65 Indebtedness (Future Maturities On Debt) (Details) HTML 47K
82: R66 Leases (Narrative) (Details) HTML 45K
83: R67 Leases (Summary Of Weighted Average Remaining HTML 39K
Lease Term And Discount Rate) (Details)
84: R68 Leases (Summary Of Components Of Lease Expense) HTML 39K
(Details)
85: R69 Leases (Summary Of Supplemental Cash Flow HTML 46K
Information Related To Leases) (Details)
86: R70 Leases (Summary Of Supplemental Balance Sheet HTML 63K
Information Related To Leases) (Details)
87: R71 Leases (Schedule Of Maturities Of Lease HTML 70K
Liabilities) (Details)
88: R72 Commitments and Contingencies (Narrative) HTML 43K
(Details)
89: R73 Revenue (Narrative) (Details) HTML 39K
90: R74 Income Taxes (Narrative) (Details) HTML 92K
91: R75 Income Taxes (Summary Of Company's Provision for HTML 60K
Income Taxes) (Details)
92: R76 Income Taxes (Summary Of Detail Of Deferred Tax HTML 61K
Assets And Liabilities) (Details)
93: R77 Income Taxes (Summary Of Difference Between HTML 80K
Effective Income Tax Rates And Federal Statutory
Rate) (Details)
94: R78 Income Taxes (Summary Of Reconciliation Of Change HTML 43K
In Federal And State Unrecognized Tax Benefits)
(Details)
95: R79 Concentrations (Narrative) (Details) HTML 42K
96: R80 Employee Benefit Plans (Narrative) (Details) HTML 41K
97: R81 Equity Compensation Plans (Narrative) (Details) HTML 141K
98: R82 Equity Compensation Plans (Activity Under Stock HTML 117K
Based Compensation Plans) (Details)
99: R83 Equity Compensation Plans (Share-Based HTML 47K
Compensation Expense Related To Employee
Share-Based Compensation) (Details)
100: R84 Equity Compensation Plans (Assumptions Used for HTML 49K
Determining Fair Value of Options) (Details)
101: R85 Equity Compensation Plans (Weighted Average HTML 41K
Estimated Grant Date Fair Value Per Share of Stock
Options, Restricted Stock Granted, And Performance
Awards) (Details)
102: R86 Equity Compensation Plans (Estimated Grant Date HTML 51K
Fair Value Per Share of Performance Options
Granted) (Details)
103: R87 Segment and Geographic Information (Narrative) HTML 31K
(Details)
104: R88 Segment and Geographic Information (Revenue By HTML 56K
Geographic Area) (Details)
105: R89 Segment and Geographic Information (Revenue By HTML 68K
Product Type) (Details)
106: R90 Selected Quarterly Financial Data (Schedule Of HTML 55K
Quarterly Financial Information) (Details)
107: R91 Schedule II (Schedule Of Valuation And Qualifying HTML 50K
Accounts) (Details)
109: XML IDEA XML File -- Filing Summary XML 210K
16: XML XBRL Instance -- atrc-20201231x10k_htm XML 7.23M
108: EXCEL IDEA Workbook of Financial Reports XLSX 134K
12: EX-101.CAL XBRL Calculations -- atrc-20201231_cal XML 296K
13: EX-101.DEF XBRL Definitions -- atrc-20201231_def XML 791K
14: EX-101.LAB XBRL Labels -- atrc-20201231_lab XML 1.67M
15: EX-101.PRE XBRL Presentations -- atrc-20201231_pre XML 1.43M
11: EX-101.SCH XBRL Schema -- atrc-20201231 XSD 217K
110: JSON XBRL Instance as JSON Data -- MetaLinks 516± 788K
111: ZIP XBRL Zipped Folder -- 0001323885-21-000011-xbrl Zip 462K
| Exhibit 1019 |
Exhibit 10.19
2014 STOCK INCENTIVE PLAN
FIRST AMENDMENT TO PERFORMANCE SHARE AWARD AGREEMENT
This First Amendment to Performance Share Award Agreement (the "Amendment") is effective as of February 25, 2021 and is entered into by and between AtriCure, Inc., a Delaware corporation (the "Company") and [_____________] (the "Grantee").
WHEREAS, the Company and the Grantee are parties to a Performance Share Award Agreement effective as of [_______] (the "Award Agreement"); and
WHEREAS, the Company and the Grantee wish to amend the Award Agreement in order to provide for modification to the calculation of the performance goal and earning of Performance Shares as set forth in the Award Agreement, including its Exhibit A.
NOW, THEREFORE, it is hereby agreed by and between the parties, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, as follows:
1.Amended Exhibit A. Effective immediately, Exhibit A is hereby amended and restated as set forth on Amended and Restated Exhibit A attached hereto and Amended and Restated Exhibit A hereby replaces and supersedes Exhibit A in its entirety.
2.Award Agreement Remains in Effect. Except as modified by this Amendment, the Award Agreement shall remain in full force and effect.
IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the day and year first written above.
ATRICURE, INC.
By: ________________________________
Name:
Title:
GRANTEE
____________________________________
[ ]
AMENDED AND RESTATED EXHIBIT A
PERFORMANCE GOALS AND PERFORMANCE PERIOD
Performance Period: Three-Year Period, Ending on December 31,________*
|
|
|
|
|
Performance Goal: |
|
Revenue CAGR
·Threshold: [___]* ·Target: [___]* ·Maximum: [___]* |
*Indicates there has been no change from the Performance Share Award Agreement
One-year revenue growth will be calculated for each year in the Performance Period. With respect to the calculation of revenue growth for each year in the Performance Period, if the Company achieves a growth rate less than the “Threshold” Performance Goal, then a 0% growth rate shall be substituted in place of such actual rate for the applicable year in the Performance Period. With respect to the calculation of revenue growth for each year in the Performance Period, if the Company achieves a growth rate greater than the “Maximum” Performance Goal, then the “Maximum” growth rate identified above be substituted in place of such actual rate for the applicable year in the Performance Period. All three years in the applicable Performance Period shall be averaged to provide the “Revenue CAGR” for purposes of determination vesting. In no event shall payouts hereunder exceed the “Target” amount of [________] Performance Shares, including in the event of a death, Permanent Disability, or Change in Control, each as defined in the Plan.
If, for the Performance Period, the Company achieves the Threshold Performance Goal set forth above, Grantee shall be entitled to [ ] Performance Shares (50% of the Target Value of Performance Shares).
If, for the Performance Period, the Company achieves the Target Performance Goal set forth above, Grantee shall be entitled to [ ] Performance Shares (100% of the Target Value of Performance Shares).
If, for the Performance Period, the Company achieves more than the Target Performance Goal set forth above, Grantee shall be entitled to [ ] Performance Shares (100% of the Target Value of Performance Shares).
If, for the Performance Period, the Grantee fails to achieve the Threshold Performance Goal set forth above, then Grantee’s right to earn Performance Shares for the Performance Period shall be forfeited automatically without further action or notice.
To the extent the actual level of attainment of the Performance Goal is at a point between the Threshold Performance Goal and Target Performance Goal, the maximum number of Performance Shares in which the Grantee can vest shall be determined based on a straight-line interpolation.
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/16/24 AtriCure, Inc. 10-K 12/31/23 102:10M 2/22/23 AtriCure, Inc. 10-K 12/31/22 99:19M 2/17/22 AtriCure, Inc. 10-K 12/31/21 101:19M 4/28/21 AtriCure, Inc. 10-Q 3/31/21 69:9.7M |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/22/20 AtriCure, Inc. 8-K:5,9 5/20/20 11:444K 4/29/20 AtriCure, Inc. 8-K:1,2,7,9 4/29/20 13:4.3M 2/24/20 AtriCure, Inc. 10-K 12/31/19 109:23M 10/31/19 AtriCure, Inc. 10-Q 9/30/19 78:12M 8/12/19 AtriCure, Inc. 8-K:1,2,3,7 8/11/19 14:7.9M Donnelley … Solutions/FA 7/31/19 AtriCure, Inc. 10-Q 6/30/19 73:10M 3/01/19 AtriCure, Inc. 10-K 12/31/18 94:15M 1/03/19 AtriCure, Inc. 8-K:1,2,9 12/28/18 2:76K Donnelley … Solutions/FA 2/26/18 AtriCure, Inc. 8-K:1,2,9 2/26/18 3:1.3M 2/16/18 AtriCure, Inc. 8-K:5,9 2/16/18 2:327K 5/27/16 AtriCure, Inc. 8-K:5,9 5/27/16 3:408K 10/05/15 AtriCure, Inc. 8-K:1,2,3,710/05/15 3:1M Certent, Inc./FA 8/25/14 AtriCure, Inc. 8-K:1,9 8/20/14 2:1.7M Donnelley … Solutions/FA 3/08/13 AtriCure, Inc. 10-K 12/31/12 94:8.6M Donnelley … Solutions/FA 11/01/12 AtriCure, Inc. 8-K:1,2,5,911/01/12 4:263K Donnelley … Solutions/FA |